The Kaplan–Meier survival analysis for early‐onset Hispanic/Latino CRC patients indicated no statistically significant difference in overall survival between those with and without PI3K pathway alterations (Figure 2). This evidence concerns the gene PIK3CG and colorectal carcinoma.